VM
Vivek Manohar Padgaonkar
About Vivek Manohar Padgaonkar
Data last updated:
Vivek Manohar Padgaonkar is a Director at Entod Pharmaceuticals Limited (since 2024), Director at Martin And Harris Laboratories Limited (since 2022) and Director at Juvenor Healthcare Limited (since 2024), and holds 2 more current directorships. The companies operate in Pharma, Healthcare and Financial Services. The 4 current companies with reported revenue have a combined latest revenue of ₹569 Cr; the largest is Entod Pharmaceuticals Limited at ₹308 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Entod Pharmaceuticals Limited U24230MH1981PLC025529 | Director | 29 Jul 2024 | 1981 | ₹308 Cr (FY 2025) | Active |
 Martin And Harris Laboratories Limited U24239HR1993PLC033630 | Director | 28 Nov 2022 | 1993 | ₹229 Cr (FY 2023) | Active |
| Juvenor Healthcare Limited U24290MH2017PLC298772 | Director | 05 Jul 2024 | 2017 | ₹20.91 Cr (FY 2025) | Active |
 Bervin Investment And Leasing Limited L65993DL1990PLC039397 | Director | 30 Sep 2022 | 1990 | ₹10.86 Cr (FY 2021) | Active |
| Paddy Advisory Services Llp ABA-9572 | Designated Partner | 06 May 2022 | 2022 | Active |
Board colleagues of Vivek Manohar Padgaonkar
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vivek Manohar Padgaonkar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vivek Manohar Padgaonkar
Vivek Manohar Padgaonkar currently holds 5 directorships: Entod Pharmaceuticals Limited (Director, since 29 Jul 2024, revenue ₹308 Cr (FY 2025)); Martin And Harris Laboratories Limited (Director, since 28 Nov 2022, revenue ₹229 Cr (FY 2023)); Juvenor Healthcare Limited (Director, since 05 Jul 2024, revenue ₹20.91 Cr (FY 2025)); Bervin Investment And Leasing Limited (Director, since 30 Sep 2022, revenue ₹10.86 Cr (FY 2021)); Paddy Advisory Services Llp (Designated Partner, since 06 May 2022).
Vivek Manohar Padgaonkar was first appointed on 06 May 2022 as Designated Partner at Paddy Advisory Services Llp. The most recent appointment on record is 29 Jul 2024 at Entod Pharmaceuticals Limited.
The 4 current companies of Vivek Manohar Padgaonkar that report revenue have a combined latest revenue of ₹569 Cr: Entod Pharmaceuticals Limited ₹308 Cr (FY 2025); Martin And Harris Laboratories Limited ₹229 Cr (FY 2023); Juvenor Healthcare Limited ₹20.91 Cr (FY 2025); Bervin Investment And Leasing Limited ₹10.86 Cr (FY 2021).
The current boards of Vivek Manohar Padgaonkar's companies include Dharmesh Pravin Kharwar (Entod Pharmaceuticals Limited), Kishore Gurudas Masurkar (Entod Pharmaceuticals Limited), Nikhil Kishore Masurkar (Entod Pharmaceuticals Limited), Rita Kishore Masurkar (Entod Pharmaceuticals Limited), Vinay Gurudas Masurkar (Entod Pharmaceuticals Limited), Vivek Rajendra Shete (Entod Pharmaceuticals Limited), among others.